Inventiva S.A. (IVA)
Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets serious conditions such as non-alcoholic steatohepatitis (NASH), various forms of mucopolysaccharidoses (MPS), and other significant diseases. The company's most advanced experimental drug is Lanifibranor, which has successfully completed Phase IIb clinical trials for the treatment of NASH. Inventiva is also progressing with Odiparcil, an asset that has finished its Phase IIa clinical studies for addressing the MPS VI subtype disease. Beyond these lead candidates, Inventiva maintains a robust pipeline of earlier-stage research and development programs, notably in oncology and other therapeutic areas. The company has also established important strategic alliances, including a partnership with AbbVie focused on treatments for autoimmune diseases, and a collaboration with Boehringer Ingelheim International GmbH aimed at discovering novel therapies for idiopathic pulmonary fibrosis. Inventiva S.A. was established in 2011 and is headquartered in Daix, France.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Inventiva S.A.
No splits on record
Nothing in IVA's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $5.02M | $10.3M | $19.56M | $13.63M | $4.69M | $416K | $7.83M | $3.58M | $7.3M | $10.57M | $5.46M | $3.67M | $3.43M |
| YoY Growth | -51.3% | -47.4% | 43.5% | 190.4% | 1027.4% | -94.7% | 118.9% | -51.0% | -31.0% | 93.8% | 48.5% | 7.1% | - |
| Cost of Revenue | $3.13M | $4.34M | -$26K | $1.11M | $1.14M | $947K | $0 | $1.08M | $1.38M | $1.66M | $1.57M | $1.71M | $1.88M |
| Gross Profit | $1.69M | $10.3M | $19.59M | $19.09M | $4.69M | $4.94M | $7.83M | $2.5M | $5.92M | $8.91M | $3.88M | $1.97M | $1.55M |
| Gross Margin | 33.7% | 100.0% | 100.1% | 140.1% | 100.0% | 1187.4% | 100.0% | 69.8% | 81.0% | 84.3% | 71.2% | 53.6% | 45.1% |
| Research and Development | $93.58M | $101.72M | $123.14M | $67.68M | $54.23M | $26.55M | $37.82M | $35.41M | $29.92M | $24.79M | $21.98M | $18.23M | $15.39M |
| Selling, General, and Administrative | $60.32M | $19.14M | $17.47M | $17.34M | $12.89M | $10.14M | $5.05M | $5.06M | $4.62M | $3.69M | $3.61M | $3.25M | $3.4M |
| Other | -$150K | -$1.37M | -$6.08M | -$2.01M | -$4.1M | $1.52M | -$2.34M | $288K | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $153.75M | $119.49M | $134.52M | $83.02M | $63.03M | $38.21M | $40.53M | $40.76M | $30.21M | $24.06M | $22.11M | $18.75M | $17.38M |
| Operating Income (EBIT) | -$146.57M | -$109.2M | -$114.96M | -$63.92M | -$58.33M | -$33.26M | -$33.93M | -$37.22M | -$23.41M | -$14.57M | -$17.36M | -$15.07M | -$13.95M |
| Operating Margin | -2921.0% | -1060.6% | -587.7% | -468.9% | -1242.6% | -7988.7% | -433.2% | -1040.1% | -320.8% | -137.8% | -318.2% | -410.2% | -406.8% |
| Interest Expense | $36.15M | $13.63M | $5.8M | $791K | $154K | $74K | $3K | $272K | $6K | $8K | $7K | $3K | $705 |
| Interest Income | $3.17M | $1.28M | $1.06M | $437K | $64K | $253K | $176K | $158K | $310K | $258K | $255K | $307K | $48K |
| Other Income (Expense) | -$236.6M | -$96.64M | -$7.96M | $3.15M | $3.18M | -$4.37M | $106K | -$124K | $311K | $515K | $544K | $834K | $838K |
| Income Before Tax (EBT) | -$383.17M | -$205.84M | -$122.92M | -$60.77M | -$55.15M | -$37.63M | -$33.82M | -$37.34M | -$23.1M | -$14.06M | -$16.82M | -$14.24M | -$13.12M |
| Income Tax Expense | $25K | $350K | $679K | -$22K | $407K | $0 | $0 | $283K | -$3.82M | -$6.17M | -$6.94M | -$5.85M | -$5.13M |
| Net Income | -$380.74M | -$206.19M | -$123.6M | -$60.75M | -$55.56M | -$37.63M | -$33.83M | -$37.63M | -$19.28M | -$7.89M | -$9.88M | -$8.39M | -$7.99M |
| Net Income Margin | -7587.8% | -2002.7% | -631.8% | -445.6% | -1183.5% | -9037.4% | -431.9% | -1051.5% | -264.2% | -74.6% | -181.0% | -228.3% | -232.8% |
| Supplementary Data | |||||||||||||
| EPS | -1.82 | -3.54 | -2.43 | -1.31 | -1.27 | -0.99 | -1.28 | -1.64 | -1.11 | -0.45 | -0.88 | -0.75 | -0.71 |
| Diluted EPS | -1.82 | -3.54 | -2.43 | -1.31 | -1.27 | -0.99 | -1.28 | -1.64 | -1.11 | -0.45 | -0.88 | -0.75 | -0.71 |
| Weighted Average OS | 186.80M | 51.98M | 45.35M | 41.45M | 39.17M | 33.87M | 23.52M | 20.54M | 15.52M | 15.68M | 10.03M | 10.03M | 10.03M |
| EBITDA | -$142.96M | -$186.39M | -$114.21M | -$62.08M | -$58.98M | -$34.4M | -$32.05M | -$35.87M | -$24.03M | -$11.65M | -$15.57M | -$13.91M | -$12.78M |
| EBITDA Margin | -2849.1% | -1810.4% | -583.9% | -455.4% | -1256.5% | -8262.4% | -409.2% | -1002.4% | -329.3% | -110.2% | -285.3% | -378.5% | -372.5% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $111.11M | $108.08M | $30.13M | $97.08M | $96.88M | $118.3M | $40.12M | $63.46M | $66.1M | $27.83M | $25.29M | $19.18M | $15.14M |
| Short-Term Investments | $0 | $0 | $78K | $1.17M | $0 | $8.21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $111.11M | $108.08M | $30.6M | $98.26M | $96.88M | $126.51M | $40.12M | $63.46M | $66.1M | $27.83M | $25.29M | $19.18M | $15.14M |
| Accounts Receivable | $10.2M | $13.61M | $17.58M | $312K | $12.97M | $54K | $720K | $14.9M | $7.68M | $5.04M | $1.1M | $3.59M | $1.7M |
| Inventory | $0 | $0 | $467K | $417K | $439K | $358K | $433K | $459K | $530K | $528K | $538K | $534K | $591K |
| Other Current Assets | $147.19M | $391K | $77K | $10.46M | $10.74M | $18.24M | $12.88M | $36K | $0 | $15.17M | $4.23M | $0 | $0 |
| Total Current Assets | $272.93M | $124.81M | $53.94M | $119.07M | $129.37M | $148.86M | $54.71M | $80.18M | $75.24M | $46.17M | $32.03M | $24.07M | $18.13M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $3.33M | $5.6M | $10.22M | $8.27M | $3.58M | $3.67M | $4.16M | $4.77M | $5.05M | $5.55M | $6.24M | $6.62M | $6.75M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $204K | $54K | $606K | $636K | $862K | $1.05M | $1.37M | $1.73M | $2.02M | $2.32M | $2.66M | $2.47M | $2.24M |
| Long-Term Investments | $590K | $1.27M | $1.6M | $784K | $1.95M | $1.9M | $2.61M | $2.54M | $267K | $432K | $26.28M | $0 | $0 |
| Deferred Tax Assets | $214K | $243K | $252K | $0 | $782K | $0 | -$2.61M | -$2.54M | $283K | $218K | $176K | $126K | $88K |
| Other Long-Term Assets | $1.3M | $1.17M | $11.25M | $1.08M | -$2K | $9K | $3.51M | $2.66M | $373K | $0 | $426K | $48.58M | $70.3M |
| Total Long-Term Assets | $5.64M | $8.35M | $23.92M | $10.77M | $7.17M | $6.63M | $9.05M | $9.15M | $8M | $8.52M | $35.77M | $57.79M | $79.38M |
| Other Assets | $0 | $0 | $0 | -$1K | -$3K | $0 | $3K | $1K | $0 | $2 | $3 | $0 | $0 |
| Total Assets | $278.57M | $133.16M | $77.86M | $129.84M | $136.54M | $155.49M | $63.76M | $89.33M | $83.24M | $54.69M | $67.8M | $81.86M | $97.51M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $29.11M | $36.78M | $42.17M | $21.67M | $16.34M | $7.75M | $8.38M | $9.37M | $6.02M | $4.89M | $4.04M | $2.11M | $1.87M |
| Short-Term Debt | $33.88M | $3.75M | $3.37M | $5.12M | $1.39M | $18K | $86K | $2.38M | $344K | $163K | $217K | $66K | $68K |
| Current Income Tax Payable | $0 | $4.39M | $3.99M | $2.4M | $1.18M | $961K | $946K | $835K | $672K | $400K | $199K | $167K | $278K |
| Current Unearned Revenue | $0 | $0 | $7K | $7K | $0 | $0 | $2.36M | $613K | $663K | $1.88M | $1.92M | $1.68M | $1.68M |
| Other Current Liabilities | $9.28M | $82.16M | $6.3M | $2.55M | $6.42M | $6.23M | $532K | $2.11M | $1.09M | $1.22M | $1.28M | $1.26M | $1.54M |
| Total Current Liabilities | $86.57M | $135.13M | $56.14M | $34.36M | $25.58M | $15.57M | $15.52M | $16.88M | $9.84M | $9.63M | $8.67M | $6.2M | $6.29M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $27.72M | $51.85M | $31.24M | $28.46M | $9.79M | $11.24M | $0 | $83K | $246K | $539K | $564K | $51K | $111K |
| Long-Term Unearned Revenue | $141K | $120K | $0 | $62K | $0 | $0 | $0 | $1.87M | $2.12M | $1.17M | $527K | $377K | $257K |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $10.41M | -$2.12M | $3.37M | $10.17M | $17.58M | $24.8M |
| Other Long-Term Liabilities | $193.53M | $63.03M | $21.55M | $12.43M | $1.6M | $4.21M | $1.9M | $1.55M | $1.5M | $1.06M | $0 | $377K | $257K |
| Total Long-Term Liabilities | $224.5M | $117.39M | $57.57M | $44.58M | $11.49M | $15.45M | $1.91M | $3.51M | $1.75M | $5.08M | $11.26M | $18.01M | $25.17M |
| Other Liabilities | $0 | $0 | $1K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $311.07M | $252.53M | $113.71M | $78.94M | $37.07M | $31.01M | $17.43M | $20.39M | $11.59M | $14.7M | $19.93M | $24.21M | $31.46M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $2.16M | $1.07M | $583K | $471K | $458K | $432K | $300K | $250K | $184K | $112K | $112K | $112K | $112K |
| Retained Earnings | -$396.39M | -$206.19M | -$123.6M | -$60.75M | -$55.56M | -$37.63M | -$33.82M | -$37.63M | -$19.28M | -$7.89M | -$9.88M | -$8.39M | -$7.99M |
| Comprehensive Income & Other | -$228.95M | -$193.14M | -$138.78M | -$83.45M | -$30.2M | $5.35M | -$16.42M | $19.62M | $40.39M | $47.76M | $57.64M | $65.93M | $73.92M |
| Other Stockholders' Equity | $361.73M | $85.75M | $87.16M | $111.18M | $154.57M | $161.68M | $79.85M | $106.32M | $90.75M | $47.76M | $57.64M | $65.93M | $73.92M |
| Total Equity | -$32.5M | -$119.37M | -$35.85M | $50.9M | $99.47M | $124.48M | $46.33M | $68.94M | $71.65M | $39.98M | $47.87M | $57.65M | $66.05M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $278.57M | $133.16M | $77.86M | $129.84M | $136.54M | $155.49M | $63.76M | $89.33M | $83.24M | $54.69M | $67.8M | $81.86M | $97.51M |
| Supplementary Data | |||||||||||||
| Total Debt | $66.48M | $60.81M | $41.96M | $38.63M | $11.33M | $11.26M | $128K | $2.47M | $540K | $702K | $781K | $117K | $180K |
| Net Debt | -$44.63M | -$47.27M | $11.83M | -$58.45M | -$85.55M | -$103.46M | -$39.99M | -$60.99M | -$65.56M | -$27.13M | -$24.51M | -$19.07M | -$14.96M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$380.74M | -$206.19M | -$123.6M | -$60.75M | -$55.56M | -$37.63M | -$33.82M | -$37.63M | -$19.28M | -$7.89M | -$9.88M | -$8.39M | -$7.99M |
| Depreciation & Amortization | $3.61M | $5.82M | $2.91M | $1.9M | $1.03M | $2.11M | $1.77M | $1.08M | $1.59M | $1.84M | $1.46M | $1.37M | $1.55M |
| Deferred Income Tax | -$2.57M | -$5.37M | -$5.31M | -$5.89M | -$3.66M | -$8.57M | -$4.81M | -$5.28M | -$8.81M | -$10.98M | -$10.98M | -$9.17M | -$7.57M |
| Stock-Based Compensation | $29.96M | $4.01M | $4.44M | $2.48M | $2.34M | $1.05M | $1.57M | $932K | $765K | $3.47M | $76K | $50K | $2K |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | $914K | $3.14M | -$6.54M | $4.3M | -$5.95M | -$514K | $1.99M | -$3.46M | $2.04M | -$3.21M | -$189K | -$41K | $1.05M |
| Inventory | $0 | $467K | -$49K | $21K | -$81K | $76K | $25K | $34K | -$1K | $10K | -$4K | $57K | -$591K |
| Accounts Payable | $2.75M | $0 | $22.39M | $3.96M | $8.51M | $1.42M | -$3.33M | $5.39M | $3.73M | $1.03M | $2.16M | $41K | -$1.05M |
| Other Working Capital | $3.52M | -$1.73M | $3.57M | -$1.89M | -$1.38M | -$3.19M | $451K | -$879K | -$2.92M | -$839K | $2K | $69K | -$246K |
| Total Working Capital Change | $7.18M | $1.88M | $19.37M | $6.39M | $1.1M | -$2.21M | -$861K | $1.09M | $2.85M | -$3M | $1.97M | $86K | $209K |
| Other Non-Cash Items | $229.53M | $103.68M | $10.83M | $5.57M | $1.44M | $11M | $4.36M | $1.52M | $3.86M | -$90K | $1.71M | -$503K | -$4.13M |
| Net Cash from Operating | -$113.03M | -$96.18M | -$91.35M | -$50.29M | -$53.31M | -$34.24M | -$31.79M | -$38.29M | -$19.03M | -$16.63M | -$15.65M | -$16.55M | -$17.92M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$266K | -$373K | -$604K | -$628K | -$598K | -$327K | -$152K | -$614K | -$479K | -$255K | -$1.08M | -$1.45M | -$2.15M |
| Acquisitions | $0 | $0 | $0 | $46K | $100K | $0 | $3K | $0 | $6.92M | $19.51M | $22.64M | $22.27M | $22.41M |
| Purchases of Investments | -$142.93M | $0 | -$9.29M | -$1K | -$1.51M | -$9.25M | -$776K | $0 | $166K | -$2K | -$431K | $0 | $0 |
| Sales of Investments | $0 | $10.16M | $1.09M | $10.51M | -$100K | $0 | $772K | $144K | $297K | $19K | $4K | $0 | $0 |
| Other Investing Activities | -$1K | $85K | $147K | $1K | $101K | $0 | -$772K | $26K | $706 | -$11K | -$33K | -$158K | $296K |
| Net Cash from Investing | -$143.19M | $9.79M | -$8.65M | $9.93M | -$2.01M | -$9.58M | -$925K | -$470K | $6.91M | $19.26M | $21.1M | $20.67M | $20.56M |
| Financing Activities | |||||||||||||
| Debt Repaid | $6.69M | -$22.3M | $4.59M | -$31.83M | $31K | -$11.07M | $309K | $290K | $163K | $79K | -$662K | $66K | -$185K |
| Common Stock Issuance | $266.11M | $64.18M | $31.43M | $9.88M | $28.51M | $113.92M | $9.69M | $36.41M | $50.55M | $0 | $0 | $0 | $84K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $265K | $76.48M | $5.71M | -$865K | -$20K | $0 | -$146K | $1K | $1K | $0 | $0 | -$2K | $84K |
| Net Cash from Financing | $259.68M | $162.96M | $32.55M | $41.71M | $28.48M | $125M | $9.38M | $36.12M | $50.38M | -$79K | $662K | -$68K | $269K |
| Forex Effect | $12.4M | $1.38M | $498K | -$1.15M | $5.42M | -$3M | $0 | $1K | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $15.86M | $77.95M | -$66.95M | $205K | -$21.42M | $78.18M | -$23.34M | -$2.64M | $38.26M | $2.54M | $6.11M | $4.05M | $2.91M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$113.03M | -$96.18M | -$91.35M | -$50.29M | -$53.31M | -$34.24M | -$31.79M | -$38.29M | -$19.03M | -$16.63M | -$15.65M | -$16.55M | -$17.92M |
| Capital Expenditure | -$266K | -$373K | -$604K | -$628K | -$598K | -$327K | -$152K | -$614K | -$479K | -$255K | -$1.08M | -$1.45M | -$2.15M |
| Free Cash Flow | -$113.3M | -$96.55M | -$91.95M | -$50.92M | -$53.91M | -$34.57M | -$31.94M | -$38.9M | -$19.51M | -$16.89M | -$16.74M | -$18M | -$20.07M |
| Cash at Beginning | $95.26M | $30.13M | $97.08M | $96.88M | $118.3M | $40.12M | $63.46M | $66.1M | $27.83M | $25.29M | $19.18M | $15.14M | $12.23M |
| Cash at End | $111.11M | $108.08M | $30.13M | $97.08M | $96.88M | $118.3M | $40.12M | $63.46M | $66.1M | $27.83M | $25.29M | $19.18M | $15.14M |